MIAMI — The math problem was evident to almost all even before the subtraction of Bam Adebayo in the first quarter of Wednesday night’s loss to the Denver Nuggets. When it comes to the center position ...

Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies The new class of GLP-1 medicines exemplifies both the ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...

Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from ...

The screw conveyor has an extensive history. Archimedes (ca. 212 BC) invented the first screw conveyor, and his design is still used today for irrigation and grain transfer. Screw conveyors became ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent implosion of Novo’s partnership with telehealth firm Hims & Hers suggests there is ...

Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...

The FDA plans to gather information from 250 compounding outsourcing pharmacies amid safety and quality concerns. In a May 1 notice, the agency said it will survey outsourcing facilities about ...

After May 22, compounding pharmacies can no longer make and sell semaglutide injections. They were initially allowed to because the FDA declared a shortage, but that period has ended. At Melrose ...